EP2118074
Efnasambönd til að hindra og meðhöndla hjarta- og æðasjúkdóma
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.2.2007EP published:
22.1.2014EP application number:
07710597.1
EP translation filed:
26.2.2014Grant published:
15.3.2014EPO information:
European Patent Register
Max expiry date:
31.1.2027Expiry date:
31.1.2027
Title:
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
Timeline
Owner
Name:
RESVERLOGIX CORP.Address:
300, 4820 Richard Road SW, AB T3E 6L1, Calgary, CA
Inventor
Name:
HANSEN, HenrikAddress:
Calgary, Alberta T2L 1E6, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
C07D 239/91, A61K 31/4375, A61K 31/472, A61K 31/496, A61K 31/517, A61K 31/519, A61K 31/5377, A61P 3/06, A61P 9/00, C07D 217/24, C07D 401/04, C07D 401/12, C07D 403/10, C07D 405/04, C07D 413/06, C07D 471/04
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 22.2.2014
Expires: 31.1.2015
Payer: Árnason Faktor
Number: 9
Paid: 6.1.2015
Expires: 31.1.2016
Payer: Árnason Faktor
Number: 10
Paid: 5.1.2016
Expires: 31.1.2017
Payer: Árnason Faktor
Number: 11
Paid: 9.1.2017
Expires: 31.1.2018
Payer: Árnason Faktor
Number: 12
Paid: 8.1.2018
Expires: 31.1.2019
Payer: Árnason Faktor
Number: 13
Paid: 9.1.2019
Expires: 31.1.2020
Payer: Árnason Faktor
Number: 14
Paid: 14.1.2020
Expires: 31.1.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.1.2021
Expires: 31.1.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.1.2022
Expires: 31.1.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 5.1.2023
Expires: 31.1.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 9.1.2024
Expires: 31.1.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 13.1.2025
Expires: 31.1.2026
Payer: Árnason Faktor ehf.
Number: 20
Paid: 4.2.2026
Expires: 31.1.2027
Payer: Árnason Faktor ehf.